This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Valens Management

Management criteria checks 2/4

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	3.8yrs
Board average tenure	3.4yrs

Recent management updates

Recent updates

These Analysts Just Made A Huge Downgrade To Their The Valens Company Inc. (TSE:VLNS) EPS Forecasts

Mar 05

CEO

Valens has no CEO, or we have no data on them.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jeffrey Fallows	President	3.6yrs	CA$536.40k	0.18% CA$ 144.7k
Sunil Gandhi	Chief Financial Officer	1.7yrs	CA$409.21k	0.019% CA$ 15.6k
Chantel Popoff	Chief Operating Officer	4.6yrs	CA$423.50k	0.17% CA$ 138.2k
Adam Shea	Chief Commercial Officer	1.7yrs	CA$401.08k	0.014% CA$ 11.6k
Scott Young	Head of Investor Relations	4.6yrs	no data	no data
Everett Knight	Executive Vice President of Corporate Development & Capital Markets	4yrs	CA$405.19k	no data
Anderson Smith	Head of Regulatory Affairs	no data	no data	no data

3.8yrs

Average Tenure

Experienced Management: VLNS's management team is considered experienced (3.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Phillip Donne	Member of Advisory Board	4.3yrs	no data	no data
Karin McCaskill	Independent Director	2.6yrs	CA$205.00k	0.012% CA$ 10.1k
Andrew Cockwell	Chairman of the Board	2.6yrs	CA$200.00k	0.55% CA$ 446.2k
Guy Beaudin	Independent Director	1.7yrs	CA$100.00k	0.081% CA$ 65.7k
Brett Channer	Member of Advisory Board	4.3yrs	no data	no data
Andrew Robson	CEO & Director	6.8yrs	CA$800.63k	2.57% CA$ 2.1m
Ashley McGrath	Independent Director	4.3yrs	CA$260.00k	0.14% CA$ 111.0k
Andrew Wolff	Independent Director	1.7yrs	CA$107.50k	0.011% CA$ 8.6k

3.4yrs

Average Tenure

48.5yo

Average Age

Experienced Board: VLNS's board of directors are considered experienced (3.4 years average tenure).

This company listing is no longer active

Valens Management

Management criteria checks 2/4

Key information

Recent management updates

The Valens Company Inc. Appoints Andrew Cockwell as its New Chair of the Board

Independent Director recently bought CA$133k worth of stock

Independent Director recently bought CA$96k worth of stock

Independent Director recently bought CA$123k worth of stock

The Valens Company Inc., Annual General Meeting, May 31, 2022

CEO & Chairman recently bought CA$114k worth of stock

Recent updates

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS).

Price target decreased to CA$1.23

Valens Gets Extension to Regain Compliance with Nasdaq

The Valens Company Inc. Withdraws All Previously Given Financial Guidance

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

The Valens Company Inc. to Report Q3, 2022 Results on Oct 13, 2022

SNDL Inc. (NasdaqCM:SNDL) entered into an arrangement agreement to acquire remaining 89.9% stake in The Valens Company Inc. (TSX:VLNS) for CAD 92.1 million.

Consensus EPS estimates fall by 259%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

The Valens Company Inc. Provides Earnings Guidance for the Year 2023

Price target decreased to CA$4.07

The Valens Company Inc. to Report Q2, 2022 Results on Jul 13, 2022

The Valens Company Receives Additional Product Listings with SQDC & Introduces Bon Jak an Exclusive Cannabis Brand in Quebec

The Valens Company Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

The Valens Company Inc. Appoints Andrew Cockwell as its New Chair of the Board

Independent Director recently bought CA$133k worth of stock

Independent Director recently bought CA$96k worth of stock

Consensus EPS estimates fall by 18%

Price target decreased to CA$5.50

Price target decreased to CA$6.04

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

The Valens Company Inc. Provides Revenue Guidance for the Year 2023

Independent Director recently bought CA$123k worth of stock

The Valens Company Inc. to Report Q1, 2022 Results on Apr 13, 2022

The Valens Company Inc. has completed a Composite Units Offering in the amount of CAD 28.124999 million.

The Valens Company Inc., Annual General Meeting, May 31, 2022

Consensus revenue estimates fall by 14%

These Analysts Just Made A Huge Downgrade To Their The Valens Company Inc. (TSE:VLNS) EPS Forecasts

No longer forecast to breakeven

The Valens Company Inc. Provides Revenue Guidance for the Year 2023

The Valens Company Inc. to Report Q4, 2021 Results on Feb 28, 2022

Consensus forecasts updated

Some Analysts Just Cut Their The Valens Company Inc. (TSE:VLNS) Estimates

Price target decreased to CA$8.22

The Valens Company Inc. Launches Two New Brands in Value and Premium Markets

The Valens Company's Ordinary Shares Deleted from Other OTC

CEO & Chairman recently bought CA$114k worth of stock

Is Valens (TSE:VLNS) Using Debt Sensibly?

Price target decreased to CA$3.81

Third quarter 2021 earnings released: CA$0.076 loss per share (vs CA$0.024 loss in 3Q 2020)

The Valens Company Inc. (TSX:VLNS) acquired Verse Cannabis Corp.

The Valens Company Inc. (TSX:VLNS) entered into an arrangement agreement to acquire Citizen Stash Cannabis Corp. (TSXV:CSC) for CAD 51.2 million.

The Valens Company Inc. and Verse Cannabis Launch New Vape Cartridges and Expand Offering to Include Cannabis-Infused Beverages

Insider recently sold CA$111k worth of stock

Second quarter 2021 earnings released: CA$0.055 loss per share (vs CA$0.028 loss in 2Q 2020)

The Valens Company Inc. (TSX:VLNS) completed the acquisition of Green Roads of Florida, LLC.

The Valens Company Enters Flower, Pre-Roll Categories and Introduces New Edibles and Concentrates Products in Partnership With Verse Cannabis

CEO & Chairman exercised options to buy CA$63k worth of stock.

The Valens Company Inc. has completed a Composite Units Offering in the amount of CAD 40.0026 million.

Independent Director has left the company

Chief Financial Officer has left the company

Vice President exercised options and sold CA$105k worth of stock

The Valens Company Inc. announced that it has received CAD 1.972159 million in funding from Sundial Growers Inc.

Consensus EPS estimates increase to -CA$0.078

Price target increased to CA$3.94

The Valens Company Inc. (TSX:VLNS) entered into a definitive agreement to acquire Green Roads of Florida, LLC for $60 million.

First quarter 2021 earnings released: CA$0.045 loss per share (vs CA$0.02 profit in 1Q 2020)

When Will The Valens Company Inc. (TSE:VLNS) Breakeven?

The Valens Company Enters First Pre-Roll Manufacturing Agreement with Experion Biotechnologies

The Valens Company Inc. completed the acquisition of LYF Food Technologies Inc.

The Valens Company Enters into Extraction and Custom Manufacturing Agreement with Rubicon Organics

Full year 2020 earnings released: CA$0.16 loss per share (vs CA$0.059 loss in FY 2019)

Revenue and earnings beat expectations

Analysts update estimates

The Valens Company Inc. to Report Q4, 2020 Results on Feb 24, 2021

The Valens Company Expands Product Distribution Capabilities with Amended Health Canada Licence to Sell Dried Cannabis Products

The Valens Company Inc. Announces the Launch of Nance's CBD 100

The Valens Company Inc. Provides Operational and Corporate Update Regarding Manufacturing Facility in Kelowna and Its Facility in the Greater Toronto Area